AI-powered Autonomous Labs Underrated?
Audience polling revealed that multimodal AI models—integrating sequencing, molecular structure, and chemistry data—are viewed as the most impactful trend in drug discovery over the next three to five years. However, panelists challenged the results by highlighting the underrated potential of autonomous labs. John Stokes argued that AI‑driven laboratory automation could eliminate slow, repetitive experimental work, freeing scientists to focus on higher‑order scientific thinking. Mohamed Al‑Quraishi echoed this view, suggesting that autonomous data generation could ease long‑standing debates around local versus global models by making high‑quality data easier to collect. Together, the discussion reframed autonomous labs as a critical enabler of future AI progress, not just a downstream application.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.